Request for Covid-19 Impact Assessment of this Report
The United States Fibromyalgia Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Fibromyalgia Treatment market, reaching US$ million by the year 2028. As for the Europe Fibromyalgia Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Fibromyalgia Treatment players cover Eli Lilly and Company, Pfizer, Novartis AG, and Allergan, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Fibromyalgia Treatment market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Antidepressants
Anticonvulsants
Muscle Relaxants
Narcotic Analgesics
Non-narcotic Analgesics
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals Pharmacies
Clinic Pharmacy
Retail Drug Stores
Online Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Eli Lilly and Company
Pfizer
Novartis AG
Allergan
Aptinyx
Prismic Pharmaceuticals
Innovative Med Concepts
Intec Pharma Ltd.
Astellas Pharma
Savella
Sun Pharmaceutical Industries
Mylan NV
Teva Pharmaceutical Industries
Daiichi Sankyo
Forest Pharmaceuticals
Meiji Seika Pharma
Tonix Pharmaceuticals
Theravance Biopharma
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Fibromyalgia Treatment Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Fibromyalgia Treatment by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Fibromyalgia Treatment by Country/Region, 2017, 2022 & 2028
2.2 Fibromyalgia Treatment Segment by Type
2.2.1 Antidepressants
2.2.2 Anticonvulsants
2.2.3 Muscle Relaxants
2.2.4 Narcotic Analgesics
2.2.5 Non-narcotic Analgesics
2.3 Fibromyalgia Treatment Sales by Type
2.3.1 Global Fibromyalgia Treatment Sales Market Share by Type (2017-2022)
2.3.2 Global Fibromyalgia Treatment Revenue and Market Share by Type (2017-2022)
2.3.3 Global Fibromyalgia Treatment Sale Price by Type (2017-2022)
2.4 Fibromyalgia Treatment Segment by Application
2.4.1 Hospitals Pharmacies
2.4.2 Clinic Pharmacy
2.4.3 Retail Drug Stores
2.4.4 Online Pharmacies
2.5 Fibromyalgia Treatment Sales by Application
2.5.1 Global Fibromyalgia Treatment Sale Market Share by Application (2017-2022)
2.5.2 Global Fibromyalgia Treatment Revenue and Market Share by Application (2017-2022)
2.5.3 Global Fibromyalgia Treatment Sale Price by Application (2017-2022)
3 Global Fibromyalgia Treatment by Company
3.1 Global Fibromyalgia Treatment Breakdown Data by Company
3.1.1 Global Fibromyalgia Treatment Annual Sales by Company (2020-2022)
3.1.2 Global Fibromyalgia Treatment Sales Market Share by Company (2020-2022)
3.2 Global Fibromyalgia Treatment Annual Revenue by Company (2020-2022)
3.2.1 Global Fibromyalgia Treatment Revenue by Company (2020-2022)
3.2.2 Global Fibromyalgia Treatment Revenue Market Share by Company (2020-2022)
3.3 Global Fibromyalgia Treatment Sale Price by Company
3.4 Key Manufacturers Fibromyalgia Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Fibromyalgia Treatment Product Location Distribution
3.4.2 Players Fibromyalgia Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Fibromyalgia Treatment by Geographic Region
4.1 World Historic Fibromyalgia Treatment Market Size by Geographic Region (2017-2022)
4.1.1 Global Fibromyalgia Treatment Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Fibromyalgia Treatment Annual Revenue by Geographic Region
4.2 World Historic Fibromyalgia Treatment Market Size by Country/Region (2017-2022)
4.2.1 Global Fibromyalgia Treatment Annual Sales by Country/Region (2017-2022)
4.2.2 Global Fibromyalgia Treatment Annual Revenue by Country/Region
4.3 Americas Fibromyalgia Treatment Sales Growth
4.4 APAC Fibromyalgia Treatment Sales Growth
4.5 Europe Fibromyalgia Treatment Sales Growth
4.6 Middle East & Africa Fibromyalgia Treatment Sales Growth
5 Americas
5.1 Americas Fibromyalgia Treatment Sales by Country
5.1.1 Americas Fibromyalgia Treatment Sales by Country (2017-2022)
5.1.2 Americas Fibromyalgia Treatment Revenue by Country (2017-2022)
5.2 Americas Fibromyalgia Treatment Sales by Type
5.3 Americas Fibromyalgia Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Fibromyalgia Treatment Sales by Region
6.1.1 APAC Fibromyalgia Treatment Sales by Region (2017-2022)
6.1.2 APAC Fibromyalgia Treatment Revenue by Region (2017-2022)
6.2 APAC Fibromyalgia Treatment Sales by Type
6.3 APAC Fibromyalgia Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Fibromyalgia Treatment by Country
7.1.1 Europe Fibromyalgia Treatment Sales by Country (2017-2022)
7.1.2 Europe Fibromyalgia Treatment Revenue by Country (2017-2022)
7.2 Europe Fibromyalgia Treatment Sales by Type
7.3 Europe Fibromyalgia Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Fibromyalgia Treatment by Country
8.1.1 Middle East & Africa Fibromyalgia Treatment Sales by Country (2017-2022)
8.1.2 Middle East & Africa Fibromyalgia Treatment Revenue by Country (2017-2022)
8.2 Middle East & Africa Fibromyalgia Treatment Sales by Type
8.3 Middle East & Africa Fibromyalgia Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Fibromyalgia Treatment
10.3 Manufacturing Process Analysis of Fibromyalgia Treatment
10.4 Industry Chain Structure of Fibromyalgia Treatment
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Fibromyalgia Treatment Distributors
11.3 Fibromyalgia Treatment Customer
12 World Forecast Review for Fibromyalgia Treatment by Geographic Region
12.1 Global Fibromyalgia Treatment Market Size Forecast by Region
12.1.1 Global Fibromyalgia Treatment Forecast by Region (2023-2028)
12.1.2 Global Fibromyalgia Treatment Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Fibromyalgia Treatment Forecast by Type
12.7 Global Fibromyalgia Treatment Forecast by Application
13 Key Players Analysis
13.1 Eli Lilly and Company
13.1.1 Eli Lilly and Company Company Information
13.1.2 Eli Lilly and Company Fibromyalgia Treatment Product Offered
13.1.3 Eli Lilly and Company Fibromyalgia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Eli Lilly and Company Main Business Overview
13.1.5 Eli Lilly and Company Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Fibromyalgia Treatment Product Offered
13.2.3 Pfizer Fibromyalgia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Novartis AG
13.3.1 Novartis AG Company Information
13.3.2 Novartis AG Fibromyalgia Treatment Product Offered
13.3.3 Novartis AG Fibromyalgia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Novartis AG Main Business Overview
13.3.5 Novartis AG Latest Developments
13.4 Allergan
13.4.1 Allergan Company Information
13.4.2 Allergan Fibromyalgia Treatment Product Offered
13.4.3 Allergan Fibromyalgia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Allergan Main Business Overview
13.4.5 Allergan Latest Developments
13.5 Aptinyx
13.5.1 Aptinyx Company Information
13.5.2 Aptinyx Fibromyalgia Treatment Product Offered
13.5.3 Aptinyx Fibromyalgia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Aptinyx Main Business Overview
13.5.5 Aptinyx Latest Developments
13.6 Prismic Pharmaceuticals
13.6.1 Prismic Pharmaceuticals Company Information
13.6.2 Prismic Pharmaceuticals Fibromyalgia Treatment Product Offered
13.6.3 Prismic Pharmaceuticals Fibromyalgia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Prismic Pharmaceuticals Main Business Overview
13.6.5 Prismic Pharmaceuticals Latest Developments
13.7 Innovative Med Concepts
13.7.1 Innovative Med Concepts Company Information
13.7.2 Innovative Med Concepts Fibromyalgia Treatment Product Offered
13.7.3 Innovative Med Concepts Fibromyalgia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Innovative Med Concepts Main Business Overview
13.7.5 Innovative Med Concepts Latest Developments
13.8 Intec Pharma Ltd.
13.8.1 Intec Pharma Ltd. Company Information
13.8.2 Intec Pharma Ltd. Fibromyalgia Treatment Product Offered
13.8.3 Intec Pharma Ltd. Fibromyalgia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Intec Pharma Ltd. Main Business Overview
13.8.5 Intec Pharma Ltd. Latest Developments
13.9 Astellas Pharma
13.9.1 Astellas Pharma Company Information
13.9.2 Astellas Pharma Fibromyalgia Treatment Product Offered
13.9.3 Astellas Pharma Fibromyalgia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Astellas Pharma Main Business Overview
13.9.5 Astellas Pharma Latest Developments
13.10 Savella
13.10.1 Savella Company Information
13.10.2 Savella Fibromyalgia Treatment Product Offered
13.10.3 Savella Fibromyalgia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Savella Main Business Overview
13.10.5 Savella Latest Developments
13.11 Sun Pharmaceutical Industries
13.11.1 Sun Pharmaceutical Industries Company Information
13.11.2 Sun Pharmaceutical Industries Fibromyalgia Treatment Product Offered
13.11.3 Sun Pharmaceutical Industries Fibromyalgia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Sun Pharmaceutical Industries Main Business Overview
13.11.5 Sun Pharmaceutical Industries Latest Developments
13.12 Mylan NV
13.12.1 Mylan NV Company Information
13.12.2 Mylan NV Fibromyalgia Treatment Product Offered
13.12.3 Mylan NV Fibromyalgia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Mylan NV Main Business Overview
13.12.5 Mylan NV Latest Developments
13.13 Teva Pharmaceutical Industries
13.13.1 Teva Pharmaceutical Industries Company Information
13.13.2 Teva Pharmaceutical Industries Fibromyalgia Treatment Product Offered
13.13.3 Teva Pharmaceutical Industries Fibromyalgia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Teva Pharmaceutical Industries Main Business Overview
13.13.5 Teva Pharmaceutical Industries Latest Developments
13.14 Daiichi Sankyo
13.14.1 Daiichi Sankyo Company Information
13.14.2 Daiichi Sankyo Fibromyalgia Treatment Product Offered
13.14.3 Daiichi Sankyo Fibromyalgia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Daiichi Sankyo Main Business Overview
13.14.5 Daiichi Sankyo Latest Developments
13.15 Forest Pharmaceuticals
13.15.1 Forest Pharmaceuticals Company Information
13.15.2 Forest Pharmaceuticals Fibromyalgia Treatment Product Offered
13.15.3 Forest Pharmaceuticals Fibromyalgia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Forest Pharmaceuticals Main Business Overview
13.15.5 Forest Pharmaceuticals Latest Developments
13.16 Meiji Seika Pharma
13.16.1 Meiji Seika Pharma Company Information
13.16.2 Meiji Seika Pharma Fibromyalgia Treatment Product Offered
13.16.3 Meiji Seika Pharma Fibromyalgia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Meiji Seika Pharma Main Business Overview
13.16.5 Meiji Seika Pharma Latest Developments
13.17 Tonix Pharmaceuticals
13.17.1 Tonix Pharmaceuticals Company Information
13.17.2 Tonix Pharmaceuticals Fibromyalgia Treatment Product Offered
13.17.3 Tonix Pharmaceuticals Fibromyalgia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Tonix Pharmaceuticals Main Business Overview
13.17.5 Tonix Pharmaceuticals Latest Developments
13.18 Theravance Biopharma
13.18.1 Theravance Biopharma Company Information
13.18.2 Theravance Biopharma Fibromyalgia Treatment Product Offered
13.18.3 Theravance Biopharma Fibromyalgia Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Theravance Biopharma Main Business Overview
13.18.5 Theravance Biopharma Latest Developments
14 Research Findings and Conclusion
Table 1. Fibromyalgia Treatment Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Fibromyalgia Treatment Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Antidepressants
Table 4. Major Players of Anticonvulsants
Table 5. Major Players of Muscle Relaxants
Table 6. Major Players of Narcotic Analgesics
Table 7. Major Players of Non-narcotic Analgesics
Table 8. Global Fibromyalgia Treatment Sales by Type (2017-2022) & (KG)
Table 9. Global Fibromyalgia Treatment Sales Market Share by Type (2017-2022)
Table 10. Global Fibromyalgia Treatment Revenue by Type (2017-2022) & ($ million)
Table 11. Global Fibromyalgia Treatment Revenue Market Share by Type (2017-2022)
Table 12. Global Fibromyalgia Treatment Sale Price by Type (2017-2022) & (USD/KG)
Table 13. Global Fibromyalgia Treatment Sales by Application (2017-2022) & (KG)
Table 14. Global Fibromyalgia Treatment Sales Market Share by Application (2017-2022)
Table 15. Global Fibromyalgia Treatment Revenue by Application (2017-2022)
Table 16. Global Fibromyalgia Treatment Revenue Market Share by Application (2017-2022)
Table 17. Global Fibromyalgia Treatment Sale Price by Application (2017-2022) & (USD/KG)
Table 18. Global Fibromyalgia Treatment Sales by Company (2020-2022) & (KG)
Table 19. Global Fibromyalgia Treatment Sales Market Share by Company (2020-2022)
Table 20. Global Fibromyalgia Treatment Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Fibromyalgia Treatment Revenue Market Share by Company (2020-2022)
Table 22. Global Fibromyalgia Treatment Sale Price by Company (2020-2022) & (USD/KG)
Table 23. Key Manufacturers Fibromyalgia Treatment Producing Area Distribution and Sales Area
Table 24. Players Fibromyalgia Treatment Products Offered
Table 25. Fibromyalgia Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Fibromyalgia Treatment Sales by Geographic Region (2017-2022) & (KG)
Table 29. Global Fibromyalgia Treatment Sales Market Share Geographic Region (2017-2022)
Table 30. Global Fibromyalgia Treatment Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Fibromyalgia Treatment Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Fibromyalgia Treatment Sales by Country/Region (2017-2022) & (KG)
Table 33. Global Fibromyalgia Treatment Sales Market Share by Country/Region (2017-2022)
Table 34. Global Fibromyalgia Treatment Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Fibromyalgia Treatment Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Fibromyalgia Treatment Sales by Country (2017-2022) & (KG)
Table 37. Americas Fibromyalgia Treatment Sales Market Share by Country (2017-2022)
Table 38. Americas Fibromyalgia Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Fibromyalgia Treatment Revenue Market Share by Country (2017-2022)
Table 40. Americas Fibromyalgia Treatment Sales by Type (2017-2022) & (KG)
Table 41. Americas Fibromyalgia Treatment Sales Market Share by Type (2017-2022)
Table 42. Americas Fibromyalgia Treatment Sales by Application (2017-2022) & (KG)
Table 43. Americas Fibromyalgia Treatment Sales Market Share by Application (2017-2022)
Table 44. APAC Fibromyalgia Treatment Sales by Region (2017-2022) & (KG)
Table 45. APAC Fibromyalgia Treatment Sales Market Share by Region (2017-2022)
Table 46. APAC Fibromyalgia Treatment Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Fibromyalgia Treatment Revenue Market Share by Region (2017-2022)
Table 48. APAC Fibromyalgia Treatment Sales by Type (2017-2022) & (KG)
Table 49. APAC Fibromyalgia Treatment Sales Market Share by Type (2017-2022)
Table 50. APAC Fibromyalgia Treatment Sales by Application (2017-2022) & (KG)
Table 51. APAC Fibromyalgia Treatment Sales Market Share by Application (2017-2022)
Table 52. Europe Fibromyalgia Treatment Sales by Country (2017-2022) & (KG)
Table 53. Europe Fibromyalgia Treatment Sales Market Share by Country (2017-2022)
Table 54. Europe Fibromyalgia Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Fibromyalgia Treatment Revenue Market Share by Country (2017-2022)
Table 56. Europe Fibromyalgia Treatment Sales by Type (2017-2022) & (KG)
Table 57. Europe Fibromyalgia Treatment Sales Market Share by Type (2017-2022)
Table 58. Europe Fibromyalgia Treatment Sales by Application (2017-2022) & (KG)
Table 59. Europe Fibromyalgia Treatment Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Fibromyalgia Treatment Sales by Country (2017-2022) & (KG)
Table 61. Middle East & Africa Fibromyalgia Treatment Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Fibromyalgia Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Fibromyalgia Treatment Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Fibromyalgia Treatment Sales by Type (2017-2022) & (KG)
Table 65. Middle East & Africa Fibromyalgia Treatment Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Fibromyalgia Treatment Sales by Application (2017-2022) & (KG)
Table 67. Middle East & Africa Fibromyalgia Treatment Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Fibromyalgia Treatment
Table 69. Key Market Challenges & Risks of Fibromyalgia Treatment
Table 70. Key Industry Trends of Fibromyalgia Treatment
Table 71. Fibromyalgia Treatment Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Fibromyalgia Treatment Distributors List
Table 74. Fibromyalgia Treatment Customer List
Table 75. Global Fibromyalgia Treatment Sales Forecast by Region (2023-2028) & (KG)
Table 76. Global Fibromyalgia Treatment Sales Market Forecast by Region
Table 77. Global Fibromyalgia Treatment Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Fibromyalgia Treatment Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Fibromyalgia Treatment Sales Forecast by Country (2023-2028) & (KG)
Table 80. Americas Fibromyalgia Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Fibromyalgia Treatment Sales Forecast by Region (2023-2028) & (KG)
Table 82. APAC Fibromyalgia Treatment Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Fibromyalgia Treatment Sales Forecast by Country (2023-2028) & (KG)
Table 84. Europe Fibromyalgia Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Fibromyalgia Treatment Sales Forecast by Country (2023-2028) & (KG)
Table 86. Middle East & Africa Fibromyalgia Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Fibromyalgia Treatment Sales Forecast by Type (2023-2028) & (KG)
Table 88. Global Fibromyalgia Treatment Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Fibromyalgia Treatment Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Fibromyalgia Treatment Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Fibromyalgia Treatment Sales Forecast by Application (2023-2028) & (KG)
Table 92. Global Fibromyalgia Treatment Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Fibromyalgia Treatment Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Fibromyalgia Treatment Revenue Market Share Forecast by Application (2023-2028)
Table 95. Eli Lilly and Company Basic Information, Fibromyalgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 96. Eli Lilly and Company Fibromyalgia Treatment Product Offered
Table 97. Eli Lilly and Company Fibromyalgia Treatment Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 98. Eli Lilly and Company Main Business
Table 99. Eli Lilly and Company Latest Developments
Table 100. Pfizer Basic Information, Fibromyalgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 101. Pfizer Fibromyalgia Treatment Product Offered
Table 102. Pfizer Fibromyalgia Treatment Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 103. Pfizer Main Business
Table 104. Pfizer Latest Developments
Table 105. Novartis AG Basic Information, Fibromyalgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 106. Novartis AG Fibromyalgia Treatment Product Offered
Table 107. Novartis AG Fibromyalgia Treatment Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 108. Novartis AG Main Business
Table 109. Novartis AG Latest Developments
Table 110. Allergan Basic Information, Fibromyalgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 111. Allergan Fibromyalgia Treatment Product Offered
Table 112. Allergan Fibromyalgia Treatment Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 113. Allergan Main Business
Table 114. Allergan Latest Developments
Table 115. Aptinyx Basic Information, Fibromyalgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 116. Aptinyx Fibromyalgia Treatment Product Offered
Table 117. Aptinyx Fibromyalgia Treatment Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 118. Aptinyx Main Business
Table 119. Aptinyx Latest Developments
Table 120. Prismic Pharmaceuticals Basic Information, Fibromyalgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 121. Prismic Pharmaceuticals Fibromyalgia Treatment Product Offered
Table 122. Prismic Pharmaceuticals Fibromyalgia Treatment Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 123. Prismic Pharmaceuticals Main Business
Table 124. Prismic Pharmaceuticals Latest Developments
Table 125. Innovative Med Concepts Basic Information, Fibromyalgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 126. Innovative Med Concepts Fibromyalgia Treatment Product Offered
Table 127. Innovative Med Concepts Fibromyalgia Treatment Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 128. Innovative Med Concepts Main Business
Table 129. Innovative Med Concepts Latest Developments
Table 130. Intec Pharma Ltd. Basic Information, Fibromyalgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 131. Intec Pharma Ltd. Fibromyalgia Treatment Product Offered
Table 132. Intec Pharma Ltd. Fibromyalgia Treatment Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 133. Intec Pharma Ltd. Main Business
Table 134. Intec Pharma Ltd. Latest Developments
Table 135. Astellas Pharma Basic Information, Fibromyalgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 136. Astellas Pharma Fibromyalgia Treatment Product Offered
Table 137. Astellas Pharma Fibromyalgia Treatment Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 138. Astellas Pharma Main Business
Table 139. Astellas Pharma Latest Developments
Table 140. Savella Basic Information, Fibromyalgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 141. Savella Fibromyalgia Treatment Product Offered
Table 142. Savella Fibromyalgia Treatment Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 143. Savella Main Business
Table 144. Savella Latest Developments
Table 145. Sun Pharmaceutical Industries Basic Information, Fibromyalgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 146. Sun Pharmaceutical Industries Fibromyalgia Treatment Product Offered
Table 147. Sun Pharmaceutical Industries Fibromyalgia Treatment Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 148. Sun Pharmaceutical Industries Main Business
Table 149. Sun Pharmaceutical Industries Latest Developments
Table 150. Mylan NV Basic Information, Fibromyalgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 151. Mylan NV Fibromyalgia Treatment Product Offered
Table 152. Mylan NV Fibromyalgia Treatment Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 153. Mylan NV Main Business
Table 154. Mylan NV Latest Developments
Table 155. Teva Pharmaceutical Industries Basic Information, Fibromyalgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 156. Teva Pharmaceutical Industries Fibromyalgia Treatment Product Offered
Table 157. Teva Pharmaceutical Industries Fibromyalgia Treatment Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 158. Teva Pharmaceutical Industries Main Business
Table 159. Teva Pharmaceutical Industries Latest Developments
Table 160. Daiichi Sankyo Basic Information, Fibromyalgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 161. Daiichi Sankyo Fibromyalgia Treatment Product Offered
Table 162. Daiichi Sankyo Fibromyalgia Treatment Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 163. Daiichi Sankyo Main Business
Table 164. Daiichi Sankyo Latest Developments
Table 165. Forest Pharmaceuticals Basic Information, Fibromyalgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 166. Forest Pharmaceuticals Fibromyalgia Treatment Product Offered
Table 167. Forest Pharmaceuticals Fibromyalgia Treatment Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 168. Forest Pharmaceuticals Main Business
Table 169. Forest Pharmaceuticals Latest Developments
Table 170. Meiji Seika Pharma Basic Information, Fibromyalgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 171. Meiji Seika Pharma Fibromyalgia Treatment Product Offered
Table 172. Meiji Seika Pharma Fibromyalgia Treatment Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 173. Meiji Seika Pharma Main Business
Table 174. Meiji Seika Pharma Latest Developments
Table 175. Tonix Pharmaceuticals Basic Information, Fibromyalgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 176. Tonix Pharmaceuticals Fibromyalgia Treatment Product Offered
Table 177. Tonix Pharmaceuticals Fibromyalgia Treatment Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 178. Tonix Pharmaceuticals Main Business
Table 179. Tonix Pharmaceuticals Latest Developments
Table 180. Theravance Biopharma Basic Information, Fibromyalgia Treatment Manufacturing Base, Sales Area and Its Competitors
Table 181. Theravance Biopharma Fibromyalgia Treatment Product Offered
Table 182. Theravance Biopharma Fibromyalgia Treatment Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2022)
Table 183. Theravance Biopharma Main Business
Table 184. Theravance Biopharma Latest Developments
List of Figures
Figure 1. Picture of Fibromyalgia Treatment
Figure 2. Fibromyalgia Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Fibromyalgia Treatment Sales Growth Rate 2017-2028 (KG)
Figure 7. Global Fibromyalgia Treatment Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Fibromyalgia Treatment Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Antidepressants
Figure 10. Product Picture of Anticonvulsants
Figure 11. Product Picture of Muscle Relaxants
Figure 12. Product Picture of Narcotic Analgesics
Figure 13. Product Picture of Non-narcotic Analgesics
Figure 14. Global Fibromyalgia Treatment Sales Market Share by Type in 2021
Figure 15. Global Fibromyalgia Treatment Revenue Market Share by Type (2017-2022)
Figure 16. Fibromyalgia Treatment Consumed in Hospitals Pharmacies
Figure 17. Global Fibromyalgia Treatment Market: Hospitals Pharmacies (2017-2022) & (KG)
Figure 18. Fibromyalgia Treatment Consumed in Clinic Pharmacy
Figure 19. Global Fibromyalgia Treatment Market: Clinic Pharmacy (2017-2022) & (KG)
Figure 20. Fibromyalgia Treatment Consumed in Retail Drug Stores
Figure 21. Global Fibromyalgia Treatment Market: Retail Drug Stores (2017-2022) & (KG)
Figure 22. Fibromyalgia Treatment Consumed in Online Pharmacies
Figure 23. Global Fibromyalgia Treatment Market: Online Pharmacies (2017-2022) & (KG)
Figure 24. Global Fibromyalgia Treatment Sales Market Share by Application (2017-2022)
Figure 25. Global Fibromyalgia Treatment Revenue Market Share by Application in 2021
Figure 26. Fibromyalgia Treatment Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Fibromyalgia Treatment Revenue Market Share by Company in 2021
Figure 28. Global Fibromyalgia Treatment Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Fibromyalgia Treatment Revenue Market Share by Geographic Region in 2021
Figure 30. Global Fibromyalgia Treatment Sales Market Share by Region (2017-2022)
Figure 31. Global Fibromyalgia Treatment Revenue Market Share by Country/Region in 2021
Figure 32. Americas Fibromyalgia Treatment Sales 2017-2022 (KG)
Figure 33. Americas Fibromyalgia Treatment Revenue 2017-2022 ($ Millions)
Figure 34. APAC Fibromyalgia Treatment Sales 2017-2022 (KG)
Figure 35. APAC Fibromyalgia Treatment Revenue 2017-2022 ($ Millions)
Figure 36. Europe Fibromyalgia Treatment Sales 2017-2022 (KG)
Figure 37. Europe Fibromyalgia Treatment Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Fibromyalgia Treatment Sales 2017-2022 (KG)
Figure 39. Middle East & Africa Fibromyalgia Treatment Revenue 2017-2022 ($ Millions)
Figure 40. Americas Fibromyalgia Treatment Sales Market Share by Country in 2021
Figure 41. Americas Fibromyalgia Treatment Revenue Market Share by Country in 2021
Figure 42. United States Fibromyalgia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Fibromyalgia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Fibromyalgia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Fibromyalgia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Fibromyalgia Treatment Sales Market Share by Region in 2021
Figure 47. APAC Fibromyalgia Treatment Revenue Market Share by Regions in 2021
Figure 48. China Fibromyalgia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Fibromyalgia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Fibromyalgia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Fibromyalgia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Fibromyalgia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Fibromyalgia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Fibromyalgia Treatment Sales Market Share by Country in 2021
Figure 55. Europe Fibromyalgia Treatment Revenue Market Share by Country in 2021
Figure 56. Germany Fibromyalgia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Fibromyalgia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Fibromyalgia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Fibromyalgia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Fibromyalgia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Fibromyalgia Treatment Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Fibromyalgia Treatment Revenue Market Share by Country in 2021
Figure 63. Egypt Fibromyalgia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Fibromyalgia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Fibromyalgia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Fibromyalgia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Fibromyalgia Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Fibromyalgia Treatment in 2021
Figure 69. Manufacturing Process Analysis of Fibromyalgia Treatment
Figure 70. Industry Chain Structure of Fibromyalgia Treatment
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...